These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 9126901)

  • 21. Proliferation and DNA fragmentation in meningioma subtypes.
    Maier H; Wanschitz J; Sedivy R; Rössler K; Ofner D; Budka H
    Neuropathol Appl Neurobiol; 1997 Dec; 23(6):496-506. PubMed ID: 9460716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The integrin inhibitor cilengitide affects meningioma cell motility and invasion.
    Wilisch-Neumann A; Kliese N; Pachow D; Schneider T; Warnke JP; Braunsdorf WE; Böhmer FD; Hass P; Pasemann D; Helbing C; Kirches E; Mawrin C
    Clin Cancer Res; 2013 Oct; 19(19):5402-12. PubMed ID: 23948974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of systemic celecoxib on human meningioma after intracranial transplantation into nude mice.
    Friedrich S; Schwabe K; Grote M; Krauss JK; Nakamura M
    Acta Neurochir (Wien); 2013 Jan; 155(1):173-82. PubMed ID: 23143216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endocrine manipulation of meningiomas with medroxyprogesterone acetate. Effect of MPA on growth of primary meningioma cells in monolayer tissue culture.
    Waelti ER; Markwalder TM
    Surg Neurol; 1989 Feb; 31(2):96-100. PubMed ID: 2522246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ubiquitous expression of cyclooxygenase-2 in meningiomas and decrease in cell growth following in vitro treatment with the inhibitor celecoxib: potential therapeutic application.
    Ragel BT; Jensen RL; Gillespie DL; Prescott SM; Couldwell WT
    J Neurosurg; 2005 Sep; 103(3):508-17. PubMed ID: 16235684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The treatment of malignant meningioma with verotoxin.
    Salhia B; Rutka JT; Lingwood C; Nutikka A; Van Furth WR
    Neoplasia; 2002; 4(4):304-11. PubMed ID: 12082546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent developments in chemotherapy for meningiomas: a review.
    Moazzam AA; Wagle N; Zada G
    Neurosurg Focus; 2013 Dec; 35(6):E18. PubMed ID: 24289126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic suppressive therapy with calcium channel antagonists for refractory meningiomas.
    Ragel BT; Couldwell WT; Wurster RD; Jensen RL
    Neurosurg Focus; 2007; 23(4):E10. PubMed ID: 17961034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of angiogenesis and growth of human non-malignant and malignant meningiomas by TNP-470.
    Yazaki T; Takamiya Y; Costello PC; Mineta T; Menon AG; Rabkin SD; Martuza RL
    J Neurooncol; 1995; 23(1):23-9. PubMed ID: 7542695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemotherapy: What is its role in meningioma?
    Sherman WJ; Raizer JJ
    Expert Rev Neurother; 2012 Oct; 12(10):1189-95; quiz 1196. PubMed ID: 23082735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Curcumin acts anti-proliferative and pro-apoptotic in human meningiomas.
    Curic S; Wu Y; Shan B; Schaaf C; Utpadel D; Lange M; Kuhlen D; Perone MJ; Arzt E; Stalla GK; Renner U
    J Neurooncol; 2013 Jul; 113(3):385-96. PubMed ID: 23666203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hydroxyurea for treatment of meningioma.
    Cusimano MD
    J Neurosurg; 1998 May; 88(5):938-9. PubMed ID: 9576275
    [No Abstract]   [Full Text] [Related]  

  • 33. AR42, a novel histone deacetylase inhibitor, as a potential therapy for vestibular schwannomas and meningiomas.
    Bush ML; Oblinger J; Brendel V; Santarelli G; Huang J; Akhmametyeva EM; Burns SS; Wheeler J; Davis J; Yates CW; Chaudhury AR; Kulp S; Chen CS; Chang LS; Welling DB; Jacob A
    Neuro Oncol; 2011 Sep; 13(9):983-99. PubMed ID: 21778190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spinal meningioma during hydroxyurea therapy. A paradoxycal case report.
    Giordano F; Savarino A; Pagni CA
    Neurol Sci; 2002 Sep; 23(3):127-9. PubMed ID: 12391498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Receptor tyrosine kinase inhibition by regorafenib/sorafenib inhibits growth and invasion of meningioma cells.
    Tuchen M; Wilisch-Neumann A; Daniel EA; Baldauf L; Pachow D; Scholz J; Angenstein F; Stork O; Kirches E; Mawrin C
    Eur J Cancer; 2017 Mar; 73():9-21. PubMed ID: 28082204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of the cell lines used in meningioma research.
    Ragel BT; Couldwell WT; Gillespie DL; Wendland MM; Whang K; Jensen RL
    Surg Neurol; 2008 Sep; 70(3):295-307; discussion 307. PubMed ID: 18261772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toll-like receptor-4 is expressed in meningiomas and mediates the antiproliferative action of paclitaxel.
    Tichomirowa MA; Theodoropoulou M; Daly AF; Yassouridis A; Hansen S; Lu J; Lange M; Goldbrunner RH; Stalla GK; Renner U
    Int J Cancer; 2008 Oct; 123(8):1956-63. PubMed ID: 18688857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medical treatment of recurrent meningiomas.
    Chamberlain MC; Barnholtz-Sloan JS
    Expert Rev Neurother; 2011 Oct; 11(10):1425-32. PubMed ID: 21955199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Chemosensitivity of cultured meningiomas].
    Tsuchida T; Matsudaira T; Yoshimura K; Matsumoto M; Shirayama Y; Numa Y; Kawamoto K
    Hum Cell; 1995 Dec; 8(4):155-6. PubMed ID: 8721084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro testing to a panel of potential chemotherapeutics and current concepts of chemotherapy in benign meningiomas.
    Balik V; Sulla I; Park HH; Sarissky M
    Surg Oncol; 2015 Sep; 24(3):292-9. PubMed ID: 26099192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.